Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

92 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-13

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Development and internal validation of an easy-to-use tool for clinical pain assessment. The tool has to be applicable in any clinical practice and without the need for expensive and complicated hospital tools to identify the source of persistent pain after the treatment of cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Self-management Support in Cancer Pain

NCT02333968

Pain

UNKNOWN NA

Vulnerability and Risk of Neuropathic Pain in Cancer

NCT06511674

Neuropathic Pain Cancer Predictive

RECRUITING NA

Co-creation of Pain Science Education for Children Living Beyond Cancer

NCT06345391

Children Living Beyond Cancer (i.e. Child Cancer Survivor)

NOT_YET_RECRUITING

Development of an Intervention to Enhance Cancer Pain Management

NCT03752268

Other Cancer

UNKNOWN NA

Improvement of Self Management for Oncologic Patients With Pain

NCT00779597

Pain Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

An adequate selection of physiotherapy treatment for persistent pain after the treatment of cancer, depends highly on the mechanism of the pain.

Pain can arise from a damaged nerve or tissue (skin, lymphatic system...). But when pain becomes chronic, alterations to the central nervous system can occur, as regulations of the facilitating and inhibiting mechanisms. These alterations may cause central sensitization pain. The body is now sensitized and cannot distinct harmful from harmless stimuli.

Each type of pain requires a specific treatment, therefore identification of the pain mechanism is crucial. Up till now, expensive and complex tests were performed in a hospital setting to determine if a patient suffers from neuropathic, nociceptive or central sensitization pain. This study aims for developping an assessment tool that does not require expensive devices but can be easily performed by any physiotherapist, within the timeframe of a standard consultation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Survivors Cancer Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diagnostic test ("PainsCan") for the identification of the dominant pain mechanisms in cancer survivers with persistent pain

Easy-to-use screening tool to identify the dominant pain mechanism by using quick clinical tests and compare their accuracy and validity with complicated reference tests.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient treated for primary cancer: breast, prostate, lung/bronchus, colon/rectum, gynecologic (uterus or ovary)
* Complete remission
* Curative treatment finished
* Ongoing hormonal and targeted treatment permitted
* Patient experiences pain (NRS minimum 3/10 during the past week)

* Pregnancy